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Adipose tissue is crucial for maintaining energy and metabolic 
homeostasis and its functionality is closely related to the adipocytes 
differentiation state. Adipogenesis is regulated by several transcription factors. 
Prep1 is an homeodomain transcription factor belonging to the TALE 
proteins, which plays an important role in hematopoiesis, organogenesis and 
development. Previous studies have indicated that Prep1 hypomorphic 
heterozygous (Prep1i/+) mice, which express only 55-57% of protein, have a 
complex metabolic phenotype. In fact, these mice present smaller but 
otherwise normally structured islets with reduced fasting and post-loading 
plasma insulin levels and increased insulin sensitivity in skeletal muscle and in 
liver which is accompanied by protection from streptozotocin-induced 
diabetes. In addition, Prep1 deficiency in mice induces a reduction of hepatic 
triglycerides synthesis and a protection from methionine and choline-deficient 
diet-induced steatohepatitis. 
In this study, I focused my attention on the role of Prep1 on the regulation of 
adipocyte differentiation and on the adipose tissue functionality. 
To understand the possible role of Prep1 in adipose tissue, I first evaluated the 
features of adipose tissue of Prep1i/+ and WT mice. Prep1i/+mice show a 
reduction of adipose tissue weight, a reduction of the area but no change in the 
number of adipocytes. In addition, expression of adipogenic markers, C/EBPα, 
GLUT4 and FABP4, is increased in adipose tissue of Prep1i/+ mice, while 
PPARγ does not change. Consistent with these data, upon insulin stimulation, 
insulin receptor (IR), AKT and MAPK phosphorylation is increased in adipose 
tissue of Prep1 hypomorphic heterozygous mice. In addition, basal and 
insulin- stimulated glucose-uptake is increased in adipocytes isolated from 
adipose tissue of Prep1i/+ mice compared to the adipocytes from WT mice. 
The increased basal uptake is fully consistent with the higher expression of 
GLUT4 on the plasma membrane of adipocytes of Prep1i/+ mice compared 
with that of control animals.  
To further study the function of Prep1 on adipocyte differentiation, I have 
analyzed Prep1 expression during different steps of adipogenesis in 3T3L1 
murine cells. Levels of Prep1 are progressively reduced during the conversion 
from 3T3L1 preadipocytes to adipocytes. Moreover, 3T3L1 adipocytes stably 
transfected with Prep1 cDNA display reduced lipid accumulation, and 
expression of C/EBPα, GLUT4 and FABP4. Interestingly, insulin molecular 
signaling pathway is less activated in presence of Prep1.  
All together these data suggest that Prep1 regulates adipocyte differentiation,  
giving a rationale to investigate Prep1 as possible new therapeutic agents in 
preventing adipose tissue dysfunctions. 
 




 Il tessuto adiposo è un organo che regola l’omeostasi energetica e 
metabolica e la sua funzionalità è strettamente correlata allo stato 
differenziativo degli adipociti. 
Prep1 è un fattore di trascrizione ad omeodominio appartenente alla famiglia 
delle proteine TALE (Three Amminoacid Loop Extension), i cui membri sono 
coinvolti nella formazione e nello sviluppo di diversi organi. Studi recenti 
hanno dimostrato che i topi eterozigoti ipomorfi per Prep1 (Prep1i/+), che 
esprimono tra il 55-57% della proteina, hanno un fenotipo metabolico 
particolare. Infatti, tali topi mostrano una riduzione delle isole pancreatiche 
associata alla riduzione dei livelli plasmatici di insulina e all’aumento della 
sensibilità insulinica nel muscolo e nel fegato. In aggiunta, i ridotti livelli di 
espressione nel topo Prep1i/+ inducono la riduzione della lipogenesi epatica e  
la protezione dalla steatoepatite indotta da dieta carente in metionina e colina. 
In questo progetto, ho focalizzato la mia attenzione sullo studio del ruolo del 
fattore di trascrizione Prep1 nella regolazione del differenziamento 
adipocitario e nella funzionalità del tessuto adiposo. 
Al fine di comprendere il possibile coinvolgimento di Prep1, ho valutato 
alcune caratteristiche del tessuto adiposo di topi Prep1i/+  e di controllo. I topi 
Prep1i/+ mostrano la riduzione del tessuto adiposo epididimale e dell’area 
adipocitaria. In aggiunta, l’espressione dei markers di differenziamneto 
adipocitario, C/EBPα, GLUT4 e FABP4 è aumentata nel tessuto adiposo dei 
topi eterozigoti per Prep1, invece l’espressione di PPARγ non varia. 
Coerentemente a questi dati, in seguito a somministrazione intraperitoneale di 
insulina, la fosforilazione del recettore dell’insulina (IR), di AKT e MAPK è 
aumentata nel tessuto adiposo dei topi Prep1i/+. In aggiunta, la captazione di 
glucosio basale e insulino stimolata è aumentata in adipociti maturi isolati da 
tessuto adiposo di topi Prep1 eterozigoti ipomorfi. L’aumento basale di 
captazione del glucosio è giustificato da un’ aumentata espressione di GLUT4 
sulla membrana plasmatica degli adipociti dei topi Prep1i/+. Per meglio 
caratterizzare il ruolo di Prep1 nel differenziamento adipocitario, ho valutato il 
livello di espressione proteica di Prep1 durante il differenziamento 
adipocitario. Esperimenti di Western Blot mostrano la riduzione significativa 
del livello proteico di Prep1 durante la conversione di fibroblasti 3T3L1 in 
adipociti maturi. Inoltre, la sovrespressione di Prep1 in adipociti 3T3L1 causa 
una significativa riduzione dei vacuoli lipidici intracellulari dopo colorazione 
con Oil Red-O e dell’espressione di C/EBPα, GLUT4 e FABP4. In aggiunta, 
adipociti 3T3L1 iperesprimenti Prep1 mostrano una ridotta capacità di risposta 
allo stimolo insulinico. Da questi dati è possibile supporre un ruolo di Prep1 
nella regolazione della stato differenziativo degli adipociti e nella funzionalità 









1.1 Adipose Tissue 
  
   Adipose tissue is the most prevalent tissue in the human body. It is 
commonly found in subcutaneous loose connective tissue and also surrounds 
internal organs. Mature adipocytes constitute the majority of cells in adipose 
tissue. Beside adipocytes, fat tissue contains several other cells types, 
including stromal-vascular cells (SVC) such as fibroblasts, smooth muscle 
cells, pericytes, endothelial cells and adipogenic progenitor cells or 
preadipocytes. Recent research shows that adipose tissue plays a more 
dynamic role than previously recognized in physiological processes of the 
whole body (Niemelä et al. 2008). 
Adipose tissue is divided into two subtypes: white and brown fat. White 
adipose tissue (WAT), the predominant type of adipose tissue in humans, is 
characterized by adipocytes with a single lipid inclusion and eccentrically 
located nucleus (Ahima & Flier 2000). It has long been recognized as the main 
site of storage of excess energy derived from food intake. White adipocytes 
store dietary energy in a highly concentrated form as triglyceride. By contrast, 
brown fat is specialized primarily for non-shivering thermogenesis. Brown 
adipocytes are characterized by multiple, smaller droplets of triglyceride, 
which are accessible for rapid hydrolysis and rapid oxidation of the fatty acids. 
Brown fat depots are present in human infants and recent evidences suggest 
that dispersed brown adipocytes might persist in adults (Guilherme et al. 
2008). 
White adipose tissue may be found in subcutaneous and visceral 
compartments and the respective adipocytes show different molecular and 
physiological features. In fact, increased visceral adipose tissue is associated 
with an increased risk of insulin resistance and cardiovascular disease, 
whereas increased subcutaneous adipose tissue is not. Adipocytes in visceral 
depots are sensitive to lipolytic stimuli, whereas adipocytes from structural 
depots (such as around the eyes and in the heel pads) do not easily release 
stored lipid. In addition, visceral adipose tissue accumulates more 
macrophages in the inflammatory status and secretes higher levels of pro-
inflammatory cytokines (Rosen & MacDougald 2006). 
Fat tissue plays an important role in numerous processes through its secretory 
products and endocrine functions. Adipocytes secrete several factors known to 
play a role in immunological responses, vascular diseases and appetite 
regulation. For example, leptin is a peptide hormone primarily made and 
secreted by mature adipocytes, and it has various biological activities, 
including appetite, food intake and body weight regulation, fertility, 
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reproduction and hematopoiesis (Niemelä et al. 2008). In addition, adipose 
tissue secretory products act in an autocrine and paracrine way to regulate 
adipocyte metabolism and growth, as well as to regulate energy homeostasis 
(Figure 1).  
 
 
                                
 
 
Figure 1: The multiple functions of white adipose tissue include the synthesis and 
secretion of  molecules.  
WAT produces more than 50 cytokines and other molecules. These adipokines engage, 
through endocrine, paracrine, autocrine or juxtacrine mechanisms of action, in a wide variety 
of physiological processes. 
Adapted from Lago F et al. Nature 2007. 3: 716–724  
                            
 
Despite the different function and distribution, adipocytes from the two types 
of white adipose tissue share many common differentiation feature. For 
example, all adipocytes derive from stem cells in a process known as 





Adipocytes derive from pluripotent mesenchymal stem cells (MSCs) 
having the capacity to develop into several cell types, i.e., adipocytes, 
myocytes, chondrocytes and osteocytes. These stem cells reside in the vascular 
stroma of adipose tissue as well as in the bone marrow, and, when 
                                                                                                   BACKGROUND 
11 
 
appropriately stimulated, undergo a multistep process of commitment in which 
the progenitor cells become restricted to the adipocyte lineage. Recruitment to 
this lineage gives rise to preadipocytes that then differentiate into adipocytes 
(Tang & Lane 2012) (Figure 2). 
 
                         
 
Figure 2: Stages of adipocytes differentiation. 
Multipotent stem cell with the capacity to differentiate along mesenchymal lineages of 
myoblast, chondroblast, osteoblast and adipocyte, gives rise to preadipocyte. When exposed to 
appropriate environmental and gene expression conditions, these cells undergo clonal 
expansion and subsequent terminal differentiation; cells enlarge in size while accumulating 
lipid vacuoles that coalesce and eventually fill the cells.  
Adapted from Romao JM et al.  Exp Biol Med 2011. 236(9):997-1004; Ricoult SJ & Manning 
BD. EMBO Rep. 2013. 14(3):242-51.  
 
White adipose tissue compartments begin to develop in late gestation and the 
rate of adipogenesis rapidly surges in response to increased nutrient 
availability, leading to a marked postnatal expansion of adipose compartments. 
Whether adipogenesis occurs in the adult adipose tissue remains controversial. 
In animal studies, white adipocyte numbers increase through puberty but are 
                                                                                                   BACKGROUND 
 
 
relatively steady in mature fat pad. However, within human adult WAT, 
adipocytes seem to undergo approximately a 10% annual turnover. Thus, 
adipogenesis takes place in adults to maintain the adipose compartment. 
(Cristancho & Lazar 2011). Adipogenesis can be divided into two phases: 
determination and terminal differentiation. Determination results in the 
conversion of the stem cell into a preadipocyte, which cannot be distinguished 
morphologically from its precursor cell but has lost the potential to 
differentiate into other cell types. In the second phase, the terminal 
differentiation, the preadipocyte takes on the characteristics of the mature 
adipocyte that acquires the machinery necessary for lipid transport and 
synthesis, insulin sensitivity and the secretion of adipocytes-specific proteins 
(Rosen & MacDougald 2006). 
Moreover, the terminal differentiation can be further divided into several 
sequential steps that have been well characterized. Briefly, the sequence of 
events includes following: (1) Growth arrest at confluence, (2) clonal 
expansion which involves synchronous entry of all cells into S phase of the 
cell cycle, leading to one or two rounds of mitosis, (3) expression of  late 
genes which is accompanied by an exit from the cell cycle and expression of 
adipocyte markers. All of these sequential steps are controlled by a network of 
interacting transcription factors operating to coordinate expression of many 
hundreds of proteins responsible for establishing the mature fat cell phenotype 
(Louet & O’Malley 2007). 
The molecular regulation of terminal differentiation is more extensively 
characterized than determination because of the use of cell lines that have a 
restricted potential to differentiate into other cell types i.e., 3T3L1 and 3T3-
F442A murine cells. Confluent 3T3L1 preadipocytes can be synchronously 
differentiated by a defined adipogenic cocktail. Maximal differentiation is 
achieved upon early hormonal induction for 48 h with a combination of 
insulin, glucocorticoids (GCs), and methylisobutylxanthine (MIX), which 
elevates intracellular cAMP levels, in the presence of fetal bovine serum. 
Dexamethasone (DXM), a synthetic GC agonist, is traditionally used to 
stimulate the GC receptor. After the first 48 h, insulin alone is required to 





1.3 Molecular regulators of adipogenesis 
 
Adipocytes differentiation involves a temporally regulated set of gene-
expression events, and understanding the underlying transcriptional networks 
is of fundamental importance. In particular, Peroxisome Proliferator‑Activated 
Receptor gamma (PPARγ) and CAAT‑enhancer‑binding protein (C/EBPs) 
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1.3.1 C/EBP  family of transcriptional factors 
 
The CCAAT/enhancer-binding proteins (C/EBPs) encompass a family 







Figure 3: Amino acid sequence relationships among C/EBP family members. 
The six gene-specific isoforms of C/EBP are presented as scaled graphics that display intra-
isoform species homology (open boxes) as well as inter-isoform conservation (pink shaded 
regions with interconnecting lines revealing relative locations). Homology is not displayed for 
the bZIP regions, which are generally highly conserved (with the exception of the 
modifications associated with the basic DBD of C/EBPζ). Stick figures represent sites of post-
translational modification, as indicated by the key. The m and h designate murine-and human-
specific initiation sites for extended forms of C/EBPα that encode a nucleolar localization 
sequence (blue shading).   
Adapted from Tsukada J et al. Cytokine. 2011.54(1):6-19. 
 
 
Similarity between C/EBP family members suggests an evolutionary history of 
genetic duplications with subsequent pressure to diversify. The resulting 
family of proteins varies in tissue specificity and transactivating ability. The 
pleiotropic effects of C/EBPs are in part in due to a tissue- and stage-specific 
expression, leaky ribosomal reading, post-transcriptional modifications, and 
variable DNA binding specificities. Several works using genetically altered 
mice to abolish expression of C/EBPs have identified the role that these 
factors play in normal tissue development and cellular function, cellular 
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proliferation and functional differentiation (Birkenmeier et al. 1989; 
Landschulz et al. 1989). 
C/EBPs are modular proteins consisting of an activation domain, a DNA-
binding basic region and a leucine-rich dimerization domain. The dimerization 
domain, known as leucine zipper, is a heptad of leucine repeats that intercalate 
with repeats of the dimer partner, forming a coiled coil of α-helices in parallel 
orientation.  
C/EBPα was the first member cloned. Expression patterns of C/EBPα mRNA 
are similar in the mouse and human with measurable levels in liver, adipose, 
intestine, lung, adrenal lung, peripheral blood mononuclear cells and placenta. 
In liver and adipose compartment, highest levels of C/EBPα mRNA are 
detected only in differentiated tissue. Two isoforms of C/EBPα are generated 
from its mRNA by ribosomal scanning mechanism. The full-length protein is 
42 kDa and contains three transactivation domains (TEI-III). TEI and TEII 
mediate cooperative binding of C/EBPα to TBP (TATA box-binding protein) 
and TFIIB, two components of the RNA polymerase II basal transcriptional 
apparatus. TEIII contains a negative regulatory subdomain.The shorter 30 kDa 
C/EBPα isoform retains its dimerization and DNA-binding domains; however, 
it possesses an altered transactivation potential compared with the 42-kDa 
isoform. 
Constitutive expression of C/EBPβ is highest in liver, intestine, lung and 
adipose tissue. Stimulation with lipopolysaccharide (LPS), IL-6, IL-1, 
dexamethasone and glucagon strongly induces C/EBPβ expression, suggesting 
a role in the mediation of the inflammatory response. Like C/EBPα, two 
C/EBPβ isoforms are generated from a single mRNA. The full-length 32-kDa 
protein, also termed LAP, encodes for the conserved activation domains found 
in other C/EBPs proteins, as well as two regulatory domains, RD1 and RD2, 
which confer DNA binding inhibition in a cell type-specific manner. The 
truncated protein, LIP, translated from the third, in-frame AUG, possesses 
only the DNA-binding and leucine zipper domains.  
C/EBPγ is a short, intronless gene, whose mRNA is ubiquitously expressed 
with highest levels found in non-differentiated, progenitor cells. 
C/EBPδ is expressed in intestines, adipose and lung, with high levels of 
expression in all tissues following LPS stimulation. The 269-amino acid 
protein encodes a leucine zipper dimerization domain and DNA-binding 
region.  
C/EBPε was originally identified from a rat genomic library. Four mRNA 
isoforms, expressed primarily in myeloid and lymphoid cells, are generated by 
the use of alternative promoters combined with differential splicing. The 
highest level of expression is detected in promyelocyte and late myeloblast-
like cell lines. 
C/EBPζ, which is induced by DNA damage, possesses a leucine zipper 
dimerization domain and DNA-binding region. This transcriptional factor 
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functions as a dominant negative inhibitor of C/EBPs transcriptional activation 
(Lekstrom-Himes & Xanthopoulos 1998). 
In the recent years, it has been demonstrated that C/EBPs appear to have 
different roles in regulation of adipocytes differentiation. After treatment of 
preadipocytes cell lines (i.e., 3T3L1 and 3T3-F442A) with inducers of 
differentiation, it is possible to observed a rapid and transient increase in 
transcription and expression of C/EBPβ and C/EBPδ. After induction of 
differentiation, preadipocytes undergo approximately two rounds of cell 
division, and subsequently cell proliferation ceases coincident with the 
transcriptional activation of C/EBPα. Induction of C/EBPα is followed by 
transcriptional activation of many genes encoding proteins involved in 
creating the adipocyte phenotype. 
Embryonic fibroblast from mice lacking both C/EBPβ and C/EBPδ expression 
are unable to differentiate in response to hormonal stimulation. However, 
ectopic expression of C/EBPβ, but no C/EBPδ, in 3T3L1 preadipocytes is 
sufficient to cause differentiation in the absence of DEX and MIX.  
Works from a several of investigators have suggested a link between 
expression of C/EBPα and some adipose-specific genes. For example, 
promoters of adipocytes genes such as GLUT4, SCD1, leptin and ap2/FABP4 
are transactivated by C/EBPs, including C/EBPα. In the absence of C/EBPα, 
adipose-specific genes are not expressed and triacylglycerol accumulation was 
not detected. Also, the conditional expression of C/EBPα in stably transfected 
clones of 3T3L1 preadipocytes is sufficient to bring about differentiation as 
measured by the cytoplasmic accumulation of lipid and the expression of 
GLUT4, ap2/FABP4 and endogenous C/EBPα (Darlington et al. 1998). 
Animals having a homozygous deletion of C/EBPα gene feature dramatically 
reduced fat accumulation in WAT and BAT pads. However, these mice 
succumb to hypoglycemia within the first week of life as a result of a failure to 





PPARs are members of the nuclear receptor superfamily and are 
characterized as adopted orphan receptor, that can be activated by a variety of 
fatty acids and their derivatives such as prostaglandins. This receptor family is 
comprised of three different subtypes (PPARα, β/δ, γ), all of which are 
important regulators of lipid and glucose metabolism in many different tissues 
including skeletal muscle, liver, adipose tissue and gut. PPARγ is found in two 
different isoforms termed PPARγ1 and PPARγ2. The latter is almost 
exclusively expressed in adipose tissue, whereas PPARγ1 is more ubiquitously 
expressed. PPARs, like other nuclear receptors, are comprised of a non-
conserved N-terminal A/B domain containing the activating function 1 (AF-1), 
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a highly conserved DNA-binding domain (DBD), a hinge region (D domain), 
and a C-terminal ligand-binding domain (LBD) containing the activating 
function 2 (AF-2). The DBD anchors PPARs to their binding sites on the DNA 
template through interactions between the two zinc fingers in this domain and 
the major groove of the DNA double helix. PPARs bind as obligate 
heterodimers with the retinoic X receptor (RXR) to direct hexanucleotide 
repeats spaced by 1 nucleotide (DR-1) termed PPAR response elements 




Figure 4: PPARγ structure. 
PPARs present different functional domain: 1- the activation function-1 region (AF-1); 2- the 
DNA binding domain (DBD) binds specific DNA sequences in the PPREs found in the 
promoter regions of genes regulated by PPARs; 3- the ligand binding domain (LBD) 
contributes to the dimerization of the receptor with RXR and binds coactivator and 
corepressor proteins here.  
Adapted from Wadosky KM & Willis MS Am J Physiol Heart Circ Physiol 2012. 
302(3):H515-26; Ahmadian M et al. Nature 2013. 19(5):557-66. 
 
There are more evidences that show that PPARγ is a prime mover of fat cell 
differentiation. This was shown first in gain-of-function experiments that 
expressed PPARγ in non-adipogenic, fibroblastic cells using retroviral vectors, 
causing a strong differentiation response. The use of high-affinity selective 
PPARγ agonists such as thiazolidinediones (TZDs) has greatly improved on 
these observations. PPARγ agonist-mediated differentiation includes lipid 
accumulation and expression of many endogenous genes typical of the 
adipocyte. Interestingly, the ability of PPARγ to promote adipogenesis is not 
limited to fibroblastic cells. Indeed, myoblastic cell lines can also be converted 
to adipocytes, particularly when the cells co-express C/EBPα in addition to 
PPARγ. 
The role of PPARγ in adipogenesis is also illustrated in studies that have 
deleted this gene in mice. The PPARγ homozygous null mutation is lethal 
relatively early in gestation (e 10-10.5), secondary to a defect in placental 
development. Interestingly, PPARγ heterozygous animals exhibit resistance to 
diet-induced obesity, although this results at least in part from elevated serum 
leptin levels and decreased food intake in these mice. In human, a role for 
PPARγ in adipogenesis is suggested by the results of clinical trials of PPARγ 
agonists in liposarcoma, a malignant tissue of adipose origin. These tumors 
exhibit a strong differentiative response to these agents; whether this leads to 
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1.4 A transcriptional cascade regulates adipocytes differentiation 
 
Adipogenesis, and in particular terminal differentiation, includes a 
series of transcriptional processes involving the sequential expression of 
several transcriptional factors, culminating in the activation of C/EBPs and 






Figure 5: A complex transcriptional cascade regulates adipogenesis. 
The transcriptional control of adipogenesis involves the activation of a variety of transcription 
factors. These proteins are expressed in a cascade in which C/EBPβ and C/EBPδ are among 
the earliest seen. These two proteins induce the expression of PPARγ, which in turn activates 
C/EBPα. C/EBPα feeds back on PPARγ to maintain the differentiated state. ADD-1/SREBP-1 
can activate PPARγ by inducing its expression as well as by promoting the production of an 
endogenous PPARγ ligand. All these factors contribute to the expression of genes that 
characterize the terminally differentiated phenotype. 
Adapted from Louet & O’Malley Cell Cycle 2007. 6(20):2448-52.2006; Ahmadian M et al. 
Nature 2013. 19(5):557-66. 
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Initially, the transcriptional factor CREB (cAMP response element-binding 
protein) induces adipocytes differentiation increasing C/EBPβ expression 
(Reusch et al. 2000; Tang & Lane 2012). C/EBPβ, together with C/EBPδ, 
promote the expression of C/EBPα and PPARγ; this induction is likely do to 
be a direct transcriptional effect through C/EBP binding site in the genes 
promoter (Rosen & Spiegelman 2000).  
Subsequently, PPARγ and C/EBPα initiate positive feedback to induce their 
own expression and also activate a large number of downstream target genes 
whose expression determines the adipocyte phenotype (Moreno-Navarrete & 
Fernàndez-Real 2012). Genetic proof of this relationship has been obtained 
from experiments in which homozygous PPARγ null cells (MEFs or ES cells) 
have been exposed to a prodifferentiative regimen. These cells do not become 
adipocytes and fail to express C/EBPα despite normal levels of C/EBPβ and δ. 
Interestingly, fibroblasts derived from C/EBPα-/- embryos have reduced levels 
of PPARγ and do not form fat when exposed to hormonal-inducing agents in 
culture. When C/EBPα is added back to these cells with retroviral vector, the 
expression of PPARγ and the ability to differentiate is restored (Rosen & 
Spiegelman 2000). 
The activation of these transcriptional factors determines the acquisition of 
mature fat phenotype. In fact, adipocyte cultures feature markedly increase of 
de novo lipogenesis and become sensitive to insulin. The role of adipocyte 
determination- and differentiation-dependent factor-1/sterol regulatory 
element-binding protein-1 (ADD-1/SREBP-1) in adipocyte differentiation has 
also been indicated in detail. ADD-1/SREBP-1 is induced during adipocyte 
differentiation stimulating the expression of many genes necessary for 
lipogenesis in vivo, such as fatty acid synthase (FAS) and adiponectin 
(Niemelä et al. 2008).  
During the adipogenic process it is possible to observe an increase of enzymes 
involved in TG metabolism including adenosine triphosphate (ATP) citrate 
lyase, malic enzyme, glycerol-3-phosphate dehydrogenase and fatty acid 
synthase.  Furthermore, adipocytes also synthesize other adipose tissue-
specific products that are not directly related to lipid and glucose metabolism. 
These include FABP4/aP2, an adipocyte specific fatty acid-binding protein, 
and GLUT4 that have been considered as intermediate markers of adipocytes 
differentiation. In addition, adipocytes produce various secreted factors 
including adipsin, angiotensin II and leptin that are regarded as late markers of 
adipocytes differentiation (Table 1). PPARγ and C/EBPα are involved in the 










Table 1: Target genes of key adipocyte transcription factors.  




1.5 Adipocytes metabolism 
 
Adipocytes control whole-body metabolism by regulating 95% of total 
body triglyceride (TG) concentration (Stahl et al. 2002). In fact, these cells 
store dietary energy in a highly concentrated form as TG, mostly in a single 
large lipid droplet. These structures are associated with a unique complement 
of proteins, which enable the sequestration or mobilization of lipids. In times 
of caloric need, triglycerides can be rapidly hydrolyzed by lipases (a process 
known as lipolysis) and the resulting fatty acids are transported to other tissues 
to be oxidized in mitochondria as an energy source. Critical to these functions 
is the capacity of the adipocytes to respond to insulin (Guilherme et al. 2008).  
 
 
1.5.1 Insulin signaling 
 
Increased plasma glucose levels induce insulin secretion from 
pancreatic β cells into the bloodstream where it increases fatty acid and 
glucose uptake in the liver, muscle and adipocytes and decreases 
gluconeogenesis in the liver (Badman & Flier 2005; Cheatham & Kahn 1995). 
In mature adipocytes insulin binds to the insulin receptor (IR), which then 
phosphorylates IR substrates (Miki et al. 2001; Zhou et al. 1999). This leads to 
the recruitment and activation of the phosphatidylinositol-3 kinase (PI3K) and 
Akt (Laviola et al. 2006). Akt signaling induces translocation of GLUT4 from 
Adipogenic transcription factors Characterized target genes 
C/EBPβ PPARγ, C/EBPα, adiponectin 
C/EBPδ PPARγ, C/EBPα 
C/EBPα PPARγ, aP2, SCD, GLUT4, insulin 
receptor, leptin, adiponectin 
SREBP-1 FAS, C/EBPβ,  adiponectin 
PPARγ aP2, C/EBPα, LPL, HSL, malic 
enzyme, acyl-CoA synthetase, FATP, 
FAT, SCD, perilipin, PEPCK, GLUT4, 
UCP1, adiponectin 
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intracellular compartments to the plasma membrane where it facilitates 
transport of glucose into the cell (Watson et al.2004). Similarly, Akt also 
induces the translocation of fatty acid transport proteins (FATPs) 1 and 4 to 
the cell surface for import of fatty acids (Stahl et al. 2002). The increased 
concentrations of glucose and fatty acids that accumulate due to insulin 
stimulation rapidly induce synthesis of TG for long-term fat storage. 
Adipocyte precursor cells, positioned in the WAT, are also affected by insulin 
signaling. Here, proteins involved in cell proliferation and differentiation, 
especially the ERK and mTOR, are activated and initiate cell division and 
differentiation of precursor cells into adipocytes thereby increasing the storage 
capacity for fatty acids (Laviola et al. 2006) (Figure 7). 
 
 
           
 
 
Figure 7: Insulin signaling pathway. 
In adipocytes, insulin promotes free fatty acid (FFA) esterification into triglycerides (TG, 
schematically represented as the three-carbon glycerol backbone with three acyl fatty acid 
chains (wavy lines)) through stimulation of glucose transporter type-4 (GLUT4)-mediated 
glucose uptake. Glucose can be converted to α-glycerol phosphate, the main source of the 
glycerol backbone of TG. Insulin signaling downregulates TG lipolysis through hormone-
sensitive lipase (HSL). Insulin stimulation of the phosphatidylinositol 3-kinase (PI3K)-
AKT/protein kinase B (PKB) pathway leads to activation of the  enzyme phosphodiesterase-3 
(PDE3). This enzyme catalyzes the breakdown of cyclic AMP (cAMP) which in turn reduces 
the activation of HSL. 
Adapted from Guilherme Nature 2008 9(5):367-77. 
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Insulin regulates lipolysis, lipogenesis and glucose and fatty acids uptake. 
Lipogenesis depends on lipoprotein lipase (LPL) that is secreted from 
adipocytes and acts on the surface of endothelial cells in the WAT where it 
hydrolyzes the lipoprotein bound TG to FFAs which are then transported into 
adipocytes by passive diffusion (Hamilton & Kamp 1999) or by fatty acid 
transporter proteins (FATPs) (Abumrad et al. 1999). Inside the adipocyte, the 
fatty acids become chaperoned by adipocyte fatty acid binding protein 4 
(FABP4/aP2) for re-esterification and conjugation to coenzyme A (coA) 
catalyzed by acyl CoA synthetases (ACS) (Fantuzzi & Mazzone 2007).  
Lipolysis is due to the activity of the hormone-sensitive lipase (HSL), that 
catalyzes the hydrolysis of TG and is activated by protein kinase A (PKA) 
mediated-phosphorylation. Insulin inhibits lipolysis reducing adenylate 
cyclase activity and, in turn, PKA (Madsen & Kristiansen 2010).  
In addition, insulin stimulates glucose uptake by inducing GLUT4 
translocation. In the absence of insulin, only ~5% of the total transporter pool 
is found on the cell surface (Leto & Saltiel 2012). Upon binding to its own 
receptor, insulin induces GLUT4 recruitment to the plasma membrane to 
promote glucose uptake (Czech et al. 1993). 
Insulin plays an important role, also, in adipocytes differentiation. In 
particular, study using IRS1-/- and IRS2-/- cells suggests that members of IRS 
family in adipocytes play a role in adipogenesis. In fact, cells lacking both 
IRS1 and IRS2 cannot undergo adipocytes differentiation and adipose tissue 
mass is dramatically reduced. Furthermore, PI3K and AKT1 are required for 
adipocytes differentiation in vitro. However, the molecular mechanism of 
insulin action on adipocytes differentiation is still under investigation (Madsen 
& Kristiansen 2010). 
 
 
1.6 Adipose tissue and diseases 
 
 The classical perception of  adipose tissue as a storage place of fatty 
acids has been replaced over the last years by the notion that adipose tissue has 
a central role in lipid and glucose metabolism and produces a large number of 
hormones and cytokines, including TNFα, IL-6, adiponectin and leptin (Hajer 
et al. 2008). 
It is clear that adipose tissue is important to several normal processes of the 
human body, but it can be involved in human disease states such as obesity, 
type 2 diabetes mellitus (T2DM) and insulin resistance (IR).  
Obesity is a chronic, multifactorial disorder that has reached epidemic 
proportions globally. It is primarily characterized by an increase of fat mass 
with development of different related disorders. Expansion of adipose organ, 
in particular of white adipose tissue, is caused by a combination of size 
increase of preexisting adipocytes (hypertrophy) and de novo adipocytes 
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differentiation (hyperplasia) (Tedesco at al. 2008). Adipogenesis has probably 
a role in the pathology of obesity; indeed, when animals are kept on a high-fat 
diet, adipocyte cell size initially increases, followed by an increase in fat cell 
number upon prolonged over-nutrition. In addition, short-term overfeeding 
studies in adults demonstrate increase in adipocyte cell number. By contrast, 
preclinical and human studies have shown that weight loss is associated with 
decreased adipocyte cell size but has no effect on adipocyte cell number 
(Cristancho & Lazar 2011). Adipocytes functionality is lost during obesity and 
has been related to adipocyte hypertrophy, disequilibrium between lipogenesis 
and lipolysis, impaired transcriptional regulation of the key factors that control 
adipogenesis and lack of sensitivity to external signals, as well as a failure in 
the signal transduction process. Thus, dysfunctional adipocytes contribute to 
abnormal utilization of fatty acids causing lipotoxicity in non-adipose tissue 
such as liver and pancreas, that is correlated with insulin resistance (Vázquez-
Vela et al. 2008). 
T2D accounts for 90% of all forms of diabetes and is most common in people 
older than 45 who are overweight. However, as a consequence of increased 
obesity among young people, it is becoming more common in children and 
young adults. T2D is a heterogeneous syndrome with many possible causes. 
This is due to the interaction of environmental factors with a genetic 
susceptibility to the disease, and it is becoming more evident that the relative 
contribution of genes and environment can differ considerably, even among 
individual whose clinical phenotype is similar (Diabetes Atlas 2006). The 
maintenance of normal glucose homeostasis depends on a precisely balanced 
and dynamic interaction between tissue sensitivity to insulin and insulin 
secretion. Type 2 diabetes develops because of defects in both insulin 
secretion and action, both of these with a genetic as well as an acquired 
component. Thus, T2D is made up of different forms each of which is 
characterized by variable degrees of insulin- resistance and beta cell 
dysfunction, and which together lead to hyperglycaemia. Insulin resistance, 
typically, is an early feature of T2D. It results from a genetically determined 
reduction in insulin sensitivity, compounded by exposure to the environmental 
factors, which further impair insulin action. Major sites of insulin resistance 
include liver and the peripheral tissues, skeletal muscle and fat. In muscle and 
fat, insulin resistance is manifested by decreased glucose uptake; in the liver, 
insulin resistance leads to failure of insulin to suppress hepatic glucose 
production, which is followed by glycogen breakdown and particularly by 
gluconeogenesis (Pickup & Williams 2005). The disease often remains 
asymptomatic and undetected for years. People with type 2 diabetes are not 
completely dependent on exogenous insulin, but may require the hormone for 
the control of blood glucose levels if this is not achieved with diet alone, 
regular exercise or with oral hypoglycaemic agents. While several  
environmental factors have been identified, discovery and characterization of 
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the genes involved in T2D has been an arduous task and has proceeded slowly. 
In the past 10 years, indeed, geneticists have devoted a large amount of effort 
to finding T2D genes. Recently, several works suggest that the family of 
homeodomain-containing transcription factors named TALE (Three 
Aminoacid Loop Extension) is strongly related to diabetes and insulin-
resistance (Kim et al. 2002; Oriente et al. 2008; Oriente et al. 2011) 
 
 
1.7 TALE proteins 
 
The three-amino acid loop extension (TALE) homeodomain proteins are 
recognized as transcription factors responsible for regulating growth and 
differentiation during vertebrate embryogenesis. The genes encoding these 
proteins are highly conserved and are present in the common ancestor of 
plants, fungi, and animals.  
TALE proteins display a highly conserved DNA binding domain of 
approximately 60 amino acids called the homeodomain (Gehring et al. 1994). 
This region is composed of three alpha helices and a flexible N-terminal arm. 
The homeodomain interacts with the DNA through the third helix making 
base-specific contacts in the major groove of DNA and through the N-terminal 
arm which contacts the minor groove of DNA. Between the first and the 
second alpha helices of the homeodomain there is an extension of three amino 
acids, virtually represented by a proline (P) – tyrosine (Y) – proline (P) in 
position 24-26. This domain has been implicated in important protein–protein 
interactions that are required for fundamental aspects of development. The 
TALE homeodomain superclass is composed of two groups: the PBC and the 
MEIS families. The PBC subclass of the TALE homeodomain proteins, 
referring to the conserved PBC motif N-terminal to the TALE homeodomain 
(Burglin 1997; Burglin 1998), includes the vertebrate Pbx proteins, fly 
Extradenticle and worm Ceh-20. The MEIS class includes Homothorax (Hth) 
in flies and the Meis and Prep proteins in vertebrates (Figure 8) (Moens & 
Selleri 2006).  
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Figure 8: Phylogeny of Hox cofactors. 
TALE homeodomain proteins are divided into two groups: the PBC family, including the 
vertebrate Pbx proteins, fly Extradenticle and worm Ceh-20, and the MEIS family, including 
vertebrate Meis and Prep, fly Homothorax (Hth) and worm Unc-62. Orange letters indicate 
mouse proteins, purple lettering indicates their zebrafish orthologs. Although in some cases 
the orthology assignments are not clear (as for pbx2 and pbx4), genetic rescue experiments in 
zebrafish have suggested that the different pbx genes are functionally identical. Similar 
information is not yet available with regard to mammalian Pbx genes. 
 
 
Cooperative function among TALE family members is critical for 
transcription regulation (Bischof et al. 1998; Chang et al. 1997; Knoepfler et 
al. 1997), and several members have been shown to function as essential 
contributors to Hox-mediated developmental programs (Chan et al. 1994; 
Mann and Chan 1996; Rauskolb and Wieschaus 1994). 
 
 
1.7.1 Prep1 protein 
 
Prep1 (Pbx regulating protein 1) is a 64 kDa ubiquitary homeodomain 
transcription factor of the three aminoacid loop extension (TALE) superclass 
of proteins mapping on the chromosome 21q.22.3. The Prep1 homeodomain is 
structurally related to the PBC homeodomain class and contains an isoleucine 
residue in the third position of the conserved WF_N sequence in the 
homeodomain. Indeed, Prep1 forms DNA-independent dimeric complexes 
with the Pbx homeodomain transcription factor, enhancing target specificity 
and regulatory function. Prep1 shares homology with MEIS proteins within 
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the homeodomain and in two well-preserved amino terminal regions termed 
HR1 and HR2 (Homology Region). HR1 and HR2 bind the N-terminal region 
of Pbx1 (PBC-A) and are essential for Prep1-Pbx1 heterodimerization, which 
in turn is required for DNA binding (Berthelsen et al. 1998). Prep1 could be 
localized both in cytoplasm and in nucleus and the heterodimerization with 
Pbx1 appears to be essential to translocate Prep1 into the nucleus to bind DNA 
target. On the other hand, Prep1 dimerization prevents nuclear export and the 
proteasomal degradation of Pbx1 prolonging its half-life (Berthelsen et al. 
1999). Formation of dimeric complex drastically increases binding affinity of 
Prep1/Pbx1 to the DNA and also broadens the DNA target selectivity of Pbx1 
to include sequences containing the TGACAG sequence (Berthelsen et al. 
1998). Together Prep1 and Pbx1 form the UEF-3 (Urokinase Enhancer Factor-
3) transcription factor, which is important in regulating the activity of the 
urokinase plasminogen activator (uPA) gene enhancer. The UEF3 DNA target 
site is a regulatory element in the promoters of several growth factor and 
protease genes, such as interleukin-3 (IL-3), stromelysin and urokinase 
plasminogen activator (uPA) (Berthelsen et al. 1996). Prep1 and Pbx1 can 
form ternary complexes with PDX-1 to regulate somatostatin gene 
transcription (Goudet et al. 1999). 
The role of Prep1 has been in part clarified by the generation of mutant mice. 
Nevertheless, Prep1 null embryos results in early lethality before gastrulation 
(E7.5) (Fernandez-Diaz et al. 2010), precluding a study of the Prep1 role in 
later developmental processes. An insertion of a retroviral vector in the first 
intron of the Prep1 gene results  in a hypomorphic mutation (Prep1i/i) that 
exhibits variable penetrance. Prep1i/i embryos, expressing 5 to 7% of protein, 
die between E17.5 and P0 and present a profound alteration in the 
hematopoietic development with a deficient radioprotection activity of fetal 
liver (FL) progenitors and all colony-forming progenitors and profound 
anemia (Ferretti et al. 2006). However, a small percentage of the Prep1i/i 
embryos are born alive and subsequently live a normal length-life. The mice 
escaping embryonic lethality show T-cell development anomalies with a 
decreased number of circulating CD4+ and CD8+ T cells and increased 
apoptosis (Penkov et al. 2005). In addition, Prep1i/i feature an impairment of 
erythropoiesis and angiogenesis accompanied by  liver hypoplasia, decreased 
hematocrit, anemia, and delayed erythroid differentiation together with a 
decrease in capillary formation (Ferretti et al. 2006). These mice show also 
alterations in eye development, in fact in most cases the size of the lens is 
strongly reduced, similar to the phenotype of Pax6-deficient mice. Prep1 
deficiency affects the expression of both TALE class partners Pbx and Meis, 
both required for embryonic hematopoiesis (Azcoitia et al 2005; Di Martino et 
al. 2001; Hisa et al. 2004). All of these effects are in part evident, although 
more weakly, also in a Prep1 heterozygous hypomorphic mice (Prep1i/+), 
expressing 55-57% of protein. 
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1.7.2 Prep1 and metabolism 
 
In our laboratory we have recently evidenced an important role of 
Prep1 in pancreas development, glucose homeostasis, regulation of insulin-
action in muscle and liver, and in the regulation of hepatic lipogenesis (Oriente 
et al. 2008; Oriente et al. 2011; Oriente et al. 2013).  
Prep1-hypomorphic mice show smaller pancreatic islet but normal 
architecture. However, these mice feature islet hypoplasia, accompanied by 
significantly reduced absolute insulin levels (both basal and postloading). The 
Prep1i/i pancreatic phenotype is characterized by also a strong reduction of 
pancreatic Pbx1 expression, emphasizing the idea that Prep1 hierarchically 
acts upstream in the network regulating pancreas development by controlling 
the levels of Pbx1. Moreover, these mice exhibit protection from 
streptozotocin-induced diabetes and enhanced insulin sensitivity with 
improved glucose uptake and insulin-dependent glucose disposal by skeletal 
muscle. This muscular  phenotype does not depend on the reduced expression 
of Pbx1, rather than on the reduced levels of the recently identified novel 
Prep1 interactor p160 Myb-binding protein (p160MBP), a molecule which is 
known to inhibit the PGC-1α-mediated glucose transport and compete with 
Pbx1 to bind Prep1. Consistent with p160MBP decrease, these mice show a 
muscle-selective increase in mRNA and protein levels of PGC-1α, 
accompanied by enhanced expression of the GLUT4 transporter and glucose 
uptake in muscle. Further experiments performed in cells overexpressing 
Prep1 have confirmed these results and have indicated that Prep1 stabilizes 
p160MBP, inducing p160MBP escape from proteasomal  and reduces the levels 
of PGC-1α and GLUT4.  
The mechanisms responsible for Prep1 action in liver differ from those in the 
skeletal muscle since Pbx1 and p160MBP are expressed at different levels. In 
fact, while there is a marked reduction of p160MBP in the skeletal muscle of the 
hypomorphic mice compared to the wild type animals, this difference has not 
detectable in the liver because in this organ the expression of p160MBP is very 
low. Thus, at variance with muscle, Prep1 major functional partner in liver 
appears to be Pbx1 rather than p160MBP.  
Prep1 deficiency in animal models improves insulin signaling in liver 
increasing hepatic glycogen content and decreasing glucose output and 
triglyceride levels. Analysis of the initial steps in insulin signaling in the 
Prep1-deficient mouse liver revealed increased tyrosine phosphorylation of 
both insulin receptor and the major IRSs present in these cells. These effects 
are paralleled by a significant reduction of expression of SYP and SHP1 
tyrosine phosphatases. The functional relevance of Prep1 control of SHP1 
versus SYP expression to hepatic sensitivity to insulin has been assessed in 
HepG2 liver cells stable transfected with Prep1. These cells feature a very 
significant reduction of insulin effect on glycogen accumulation. In particular, 
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expression of SHP1 in cellular models negatively correlates with insulin 
signaling. However, antisense silencing of SHP1 rescued insulin effect in 
these cells, thus establishing SHP1 as the functionally relevant target of Prep1 
in the liver. The regulatory region of SHP1 gene contains several Prep1 
binding sites in the 4,000 base-pair region upstream SHP1 transcription 
initiation site and one Prep1/Pbx1 binding site responding to the ectopic 
expression of Prep1 and Pbx1 in cotransfection experiments in vitro. In these 
assays, a fragment containing single Prep1/Pbx1 binding site displays a 
powerful enhancer function. Thus, Prep1-Pbx1 complex enhances SHP1 gene 
transcription by acting on regulatory sequences upstream the ATG codon. 
Prep1 action in liver is not limited to the regulation of glucose metabolism but 
also on lipid synthesis (Oriente et al. 2013). In fact, serum triglyceride levels 
are strongly reduced in Prep1 heterozygous hypomorphic mice, confirming 
previous data about the reduction of hepatic triglyceride content (Oriente et al. 
2011). Indeed, FAS expression, an enzyme that regulates de novo hepatic 
lipogenesis, is significantly reduced in Prep1 deficient mice. Consistent with 
these data, the molecular pathway controlling hepatic lipogenesis is 
downregulated. In fact, in Prep1i/+ mice liver there is an increase of 
phosphorylation of PKCzeta, LKB1, AMPK and ACC, leading to an inhibition 
of TG synthesis. This regulation is due to the modulation of expression of 
SHIP2, a lipid phosphatase, known inhibitor of PI3Kinase/PKCzeta signaling. 
In the liver of Prep1 deficient mice SHIP2, protein and mRNA expression, is 
strongly reduced. Accordingly with these data,  HepG2 cells overexpressing 
Prep1 display increased triglyceride levels and FAS expression, PKCzeta, 
LKB1, AMPK and ACC phosphorylation is strongly reduced, while SHIP2 
levels are increased. Interestingly, overexpression of Pbx1 cDNA in HepG2 
cells mimicks Prep1-induced triglyceride synthesis. At the opposite, Prep1HR1 
mutant, which is unable to bind Pbx1,  fails to elicit these effects. ChIP and 
Re-ChIP experiments indicate that Prep1/Pbx1 complex can bind SHIP2 
promoter region and regulate its expression. Treatment with a methionine and 
choline-deficient (MCD) diet induces steatosis in both Prep1i/+ and non-
hypomorphic control mice. However, alanine aminotransferase increase, 
intracellular TG content and histological evidence of liver steatosis, 
inflammation and necrosis is less evident in Prep1i/+ mice, indicating that 
Prep1 silencing protects mice from MCD diet –induced steatohepatitis 
(Oriente et al. 2013). 
On the basis of the results, Prep1 might be considered as a new gene involved 








2. AIM OF THE STUDY 
The primary function of adipose tissue is to store energy in the form of 
triglycerides during period of energy excess and to release the energy during 
fasting as free fatty acids and glycerol. In addition, adipose tissue secretes a 
variety of peptides called adipocytokines that have endocrine, autocrine and 
paracrine effects on the brain, liver and skeletal muscle. These peptides play 
an important role in the regulation of energy homeostasis and intermediary 
metabolism. Dysfunction of adipose tissue may result in insulin resistance, 
type 2 diabetes mellitus and obesity (Garg 2006). 
Prep1 is an homeodomain transcription factor that regulates the overall size of 
the organism and individual organs as well as major developmental pathways. 
Data produced in our lab indicate that Prep1 hypomorphic mice (Prep1i/+) 
have a complex metabolic phenotype characterized by increased insulin 
sensitivity accompanied by protection from streptozotocin-induced diabetes. 
In muscle tissue, Prep1 deficiency positively modulates the intracellular pool 
of GLUT4 by enhancing the transcription of PGC-1α gene. In the liver, the 
mechanism is independent on PGC-1α and the improvement of insulin 
signaling is characterized by a reduction of tyrosine phosphatases SHP1, 
whose transcription is mediated by Prep1 and by an increase of insulin-
stimulated insulin receptor and IRS1/2 tyrosine phosphorylation. In addition, 
Prep1 deficiency in mice induces a reduction of hepatic triglycerides synthesis 
and a protection from methionine and choline-deficient diet-induced 
steatohepatitis. In fact, in Prep1i/+ mice liver there is an increase of 
phosphorylation of PKCzeta, LKB1, AMPK and ACC, leading to an inhibition 
of TG synthesis. This regulation is due to the modulation of expression of 
SHIP2, a lipid phosphatase, known to be an inhibitor of PI3Kinase/PKCzeta 
signaling. 
Thus Prep1 regulates several aspects of whole body metabolism (Oriente et al. 
2008; Oriente et al. 2011; Oriente et al. 2013), but whether and how Prep1 
affects adipose compartment is still unknown. The aim of my project is to 
investigate the role of Prep1 on adipogenesis and adipose tissue function, by 
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3. MATERIALS AND METHODS 
 
3.1 Materials 
Media, sera, antibiotics for cell culture and the lipofectamine reagent 
were from Invitrogen (Grand Island, NY). The Prep1, actin, C/EBPα, FABP4, 
PPARγ, pAKT-Ser473 and MAPK antibodies were from Santa Cruz 
Biotechnology, Inc. (Santa Cruz, CA). The GLUT4 antibody was from 
Abcam, Inc. (Cambridge, MA). The p-IR-Tyr1146, IR, pMAPK, antibodies 
were from Cell Signaling Tecnology, Inc. The AKT antibody was from 
Millipore Corporation (Billerica, MA). Protein electrophoresis and Real Time 
PCR reagents were purchased from Bio-Rad (Hercules, CA), Western blotting 
and ECL reagents from Amersham Biosciences (Arlington Heights, IL). Oil 
Red O stain and all other chemicals were from Sigma (St. Louis, MO). 
 
3.2 Generation of Prep1 hypomorphic mice 
Prep1 targeted mice were generated by gene trapping by Lexikon 
Genetics, Inc. (The Woodlands, Texas) and have been previously described 
(Ferretti et al. 2006; Penkov et al. 2005; Fernandez-Diaz et al. 2010). In the 
experiments reported in this paper, heterozygous mice were backcrossed with 
wild-type (WT) C57BL/6J for 4 generations. All animal handling conformed 
to regulations of the Ethics Committee on Animal Use of H. S. Raffaele 
(IACUC permission number 207). Adipose tissue samples were collected and 
weighed after mice were sacrificed by pentobarbitone overdose. Tissues were 
snap frozen in liquid nitrogen and stored at –80°C for subsequent western 
blotting and Real Time RT-PCR analysis. 
 
3.3 Adipose tissue histological and immunohistochemical analysis 
For the histological examination, epididymal adipose tissue from killed 
mice were immediately incised and weighed. Small pieces were fixed in 10% 
formalin and stained with haematoxylin and eosin for histological analysis. 
Image-Pro Plus© program was used for area and cells number measurement. 
For cells number measurement, HPF means High Power Field that is the area 
visible under the maximum magnification power of the objective being used. 
For immunohistochemical examination, frozen sections (6μm) were fixed in 
acetone at 4°C for 5 min, then blocked for endogenous peroxidase in 0.3% 
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H2O2 in methanol for 20 min. Adipose sections were further incubated with 
mouse monoclonal antibody against GLUT4 (dilution 1:50) overnight at 4°C. 
Slides were washed three times with PBS, incubated with biotinylated anti-
mouse and labeled streptavidin biotin (LSAB kit; DakoCytomation, Glostrup, 
Denmark) for 30 min, followed by incubation with streptavidin conjugated to 
horseradish peroxidase (LSAB Kit; DakoCytomation, Denmark). Color 
development was assessed following 5 min of diaminobenzidine treatment 
(DakoCytomation, Denmark) treatment. Sections were counterstained with 
Mayer’s haematoxylin. In the corresponding negative control section, the 
primary antibody was either omitted or replaced with normal mouse serum. 
 
 
3.4 Mouse mature adipocytes isolation and [U-14C]glucose uptake assay 
 Isolated mouse adipose cells of epididymal fat pads from male 6-
months-old Prep1i/+ and WT littermates were prepared by Type 1 collagenase 
digestion (1mg/ml) in KRBH-5% BSA buffer (Krebs Ringer Bicarbonate 
Hepes buffer, pH 7.4 containing 30mmol/L Hepes, 10mM NaHCO3, 0.12M 
NaCl, 4mM KH2PO4, 1mM MgSO4, 1mM CaCl2, 200nM adenosine and 5% 
BSA) at 37°C on shaking. After 2 hours of digestion, cells were filtered 
through a 250μM nylon mesh filter and then washed 3 times with KRBH-5% 
BSA buffer. After the final wash, cells were ready to use. Cells were counted 
using TC10 Automated cell counter (Biorad Laboratories, Inc. Hercules, CA) 
according to the manufacturer's instructions. Aliquots of adipose cells were 
incubated with or without 10KμU/ml (60nmol/L) insulin for 30 minutes before 
adding [U-14C]glucose (0.5μCi/ml) at 37°C on shaking. After 30 minutes 
aliquots of each samples were put in tubes with dinonylphthalate oil and 
spinned to separate the cells with aqueous phase. Scintillation liquid was 




3.5 Cell culture procedures and transfection 
3T3L1 murine fibroblast cells were available in host laboratory. They 
were grown in Dulbecco’s modified Eagle’s medium (DMEM) supplemented 
with 10% calf serum (FCS), 100 IU/ml penicillin, 100 IU/ml streptomycin, 
and 2% L-glutamine in a 5% humidified CO2 incubator. 3T3L1 cells were 
differentiated as previously described (Engelman et al. 1998). In brief, after 2 
days from confluence (Day 0), the DMEM 10% FCS was changed and new 
DMEM 10% FBS was added to the cells with the addition of 174nM insulin, 
10mM dexamethasone and 0.5mM 3-isobutyl-1-methylxanthine. After 2 days 
(Day 2), this medium was replaced with fresh DMEM 10% FCS containing 
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only 174nM insulin. After another 2 days, the cells were then propagated in 
only 10% FCS medium.  
3T3L1 stable transfection of Prep1 and PRC/CMV plasmid cDNAs were 
performed by the Lipofectamine reagent (Invitrogen) according to the 
manufacturer’s instruction. For these studies, 60-80% confluent cells were 
washed twice with Optimem and incubated for 8h with 3-5 g of plasmid 
construct and 45-60 μl of Lipofectamine reagent. In stably transfection 
individual G418-resistant clones were selected by the limiting dilution 
technique (G418 effective dose, 0.8 mg/ml). 
 
 
3.6 Oil Red O-staining 
To measure cellular neutral lipid droplet accumulation, 3T3L1 cells 
were stained by the Oil Red O method. Prep1 stably transfected 3T3L1 cells 
were differentiated as described above. Mature adipocytes were washed three 
times with iced PBS and fixed with 4% paraformaldehyde for 30 minutes. 
After fixation, cells were washed three times and stained with Oil Red O 
solution (working solution, 0.5g Oil Red O powder Sigma dissolved in 60% 
ethanol) for 15 min at room temperature. Cells were washed again with 
phosphate-buffered saline (PBS) to remove unbound staining. The 3T3L1 
adipocytes were examined under a light microscope, and the red oil droplets 
stained in the cells indicate TG accumulation. The ORO was extracted in 
100% isopropanol and absorbance was evaluated at 510nm as previously 
described (Ramirez-Zacarias et al. 1992). 
 
 
3.7 Western blot analysis  
Tissue samples were homogenized in a Polytron (Brinkman 
Instruments, N.Y.) in 20 ml T-PER reagent/gram of tissue according to 
manufacture (Pierce, IL). After centrifugation at 10,000 rpm for 5 minutes, 
supernatant was collected. Cells were solubilized in lysis buffer (50 mmol/l 
HEPES, pH 7.5, 150 mmol/l NaCl, 10 mmol/L EDTA, 10 mmol/l Na4P2O7, 2 
mmol/L Na3VO4, 100 mmol/L NaF, 10% glycerol, 1% Triton X-100, 1 
mmol/L PMSF, 10 mg/ml aprotinin) for 1 h at 4C and lysates were centrifuged 
at 5,000g for 20 min. Total homogenates were separated by SDS-PAGE and 
transferred on 0.45 m Immobilon-P membranes. Upon incubation with 
primary and secondary antibodies, immunoreactive bands were detected by 
ECL according to the manufacturer's instructions. 
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3.8 Real-Time RT-PCR analysis 
Total cellular RNA was isolated from adipose tissue and 3T3L1 cells 
by using the RNeasy Lipid kit (QIAGEN Sciences, Germany), according to 
manufacturer’s instructions. 1 μg of tissue or cell RNA was reverse-
transcribed using Superscript III Reverse Transcriptase (Invitrogen, CA). PCR 
reactions were analyzed using SYBR Green mix (Bio-Rad, Hercules, CA). 
Reactions were performed using Platinum SYBR Green qPCR Super-UDG 
using an iCycler IQ multicolor Real Time PCR Detection System (Bio-rad, 
Hercules, CA). All reactions were performed in triplicate and β-actin was used 
as an internal standard. Primer sequences used were as follows:  
C/EBPα F: 5' TTACAACAGGCCAGGTTTCC 3’ 
R: 5’ CTCTGGGATGGATCGATTGT 3’ 
GLUT4 F: 5’ CAGAAGGTGATTGAACAGAG 3’ 
R: 5’ AATGATGCCAATGAGAAAGG 3’ 
FABP4 F: 5’ AATCACCGCAGACGACAG 3’ 
R: 5’ ACGCCTTTCATAACACATTCC 3’ 
PPARγ F: 5’ TGGTGCCTTCGCTCATGC 3’ 
R: 5’ CTGTGGTAAAGGGCTTGATGTC 3’ 
PREP1 F: 5' CCTGGGACAATTAGGATCCAGAACT 3' 
R: 5' TCCTCTGTTGGGTAGGGATGCC 3' 
β-ACTIN F: 5’ CGCCCTAGGCACCAGGGTGTG 3’ 
R: 5’ TCGGTGAGCAGCACAGGGTG 3’ 
 
 
3.9 Statistical procedures 
Data were analysed with the Statview software (Abacus-concepts) by 










4.1 Characterization of Prep1 hypomorphic heterozygous mice adipose 
tissue  
  
 To investigate the impact of Prep1 deficiency in adipose compartment, 
I first evaluated  the epididymal adipose tissue weight of  wild-type (WT) and 
Prep1i/+  mice. As shown in figure 9, a reduction of epididymal fat pad weight 
in Prep1 hypomorphic heterozygous mice was observed. 
            
                      
                                                        
 
 
Figure 9: Epididymal adipose tissue weight of Prep1i/+and WT mice. 
Adipose tissue of Prep1i/+ and WT mice were dissected and weighed. The graphs show 
percent of epididymal adipose tissue weight/total body weight. Values are means ±SD of six 
mice for groups of five different evaluation. (*P < 0.05).  
 
Next, I performed an histological analysis of adipose tissue of Prep1i/+  and 
WT mice. Hematoxylin-eosin staining revealed that Prep1 hypomorphic 
heterozygous adipocytes had a significantly reduced cell area 
(6149.25±1070.18 μm2) compared to the adipocytes of the WT mice 
(9605.94±2522.07 μm2) (figure 10).   
 





Figure 10: Histological analysis of adipose tissue from Prep1i/+ and WT mice. 
Sections from epididymal adipose tissue from 6-months-old Prep1i/+ and WT littermates were 
stained with hematoxylin-eosin (original magnification 40X). The microphotographs shown 
are representative of findings observation in five Prep1i/+ and seven control animals. Image-
Pro Plus© program was used for area measurement. Values were obtained from eight different 
observation in five Prep1i/+ and seven control animals. (**P < 0.01).  
 
Despite the reduced cell area, there was no significant difference in cell 
number between WT (57±16 cells/HPF) and Prep1i/+ (72±26 cells/HPF)  
adipocytes (figure 11). 
 
                             
 
Figure 11: Adipocytes number of Prep1i/+ mice. 
Sections from epididymal adipose tissue from 6-months-old Prep1i/+ and WT littermates were 
stained with hematoxylin-eosin. Image-Pro Plus© program was used for cells number 




measurement. Values were obtained from eight different observation in five Prep1i/+ and 
seven control animals 
 
4.2 Prep1 deficiency leads to increased expression of adipogenic markers 
 
To further study the function of Prep1, I evaluated the expression of 
some markers of adipocytes differentiation, including C/EBPα, GLUT4, 
FABP4 and PPARγ in Prep1 hypomorphic heterozygous and WT mice. In 
adipose tissue of Prep1i/+ mice there was a significant increase of C/EBPα, 
GLUT4 and FABP4 mRNA expression, while PPARγ expression level did not 
change (figure 12). 
 
                                                                             
      
Figure 12: C/EBPα, GLUT4, FABP4 and PPARγ mRNA levels in Prep1i/+ mice. 
The abundance of C/EBPα, GLUT4, FABP4 and PPARγ mRNAs were determined by real-
time RT-PCR analysis of total RNA isolated from the adipose tissue of heterozygous and 
control mice, using β-actin as internal standard. Bar represents the mean ± SD of four 
independent experiments, in each of which reactions were performed in triplicate using total 
RNAs obtained from eight mice per genotype. Asterisks denote statistically significant 
differences (*P<0.05; **P < 0.01).  
 
Consistent with these data, protein expression of C/EBPα, GLUT4 and FABP4 
was increased in the adipose tissue of  Prep1i/+ mice, while PPARγ protein 
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Figure 13: C/EBPα, GLUT4, FABP4 and PPARγ protein levels in Prep1i/+mice. 
Tissues from Prep1 hypomorphic heterozygous and control mice were dissected, solubilized, 
and protein samples analyzed by Western blot with C/EBPα, GLUT4, FABP4 and PPARγ 
antibodies. Actin antibody was used for normalization. Blot were revealed by ECL and 
autoradiograph is representative of three independent experiments. 
 
 
4.3 Insulin signaling and [U-14C]glucose uptake in adipose tissue of Prep1-
deficient mice 
 
 To investigate the role of Prep1 in adipose tissue function, WT and 
Prep1i/+  mice were intraperitoneally injected with insulin (0,15U/g) and the 
activation of the downstream molecular effectors were analyzed by Western 
blot. As shown in figure 14, in adipose tissue of Prep1 hypomorphic 
heterozygous mice I observed a significant increase of insulin receptor (IR)-
tyrosine phosphorylation, upon insulin stimulation, while protein level did not 
change. Both the downstream effectors, AKT and MAP kinases, were also 
more activated in the Prep1i/+  mice, with no difference in their expression. 
 





Figure 14: Insulin receptor, AKT and MAP kinase phosphorylation in Prep1i/+ mice. 
Tissues from Prep1 hypomorphic heterozygous and control mice were dissected, solubilized, 
and protein samples analyzed by Western blot with pIR-Tyr1146, IR, pAKT –Ser473, AKT, 
pMAPK, MAPK antibodies. Actin antibody was used for normalization. Blot were revealed 
by ECL and autoradiograph is representative of three independent experiments.  
 
Next, I measured the insulin-stimulated [U-14C]glucose uptake of mature 
adipocytes isolated from Prep1i/+ and WT mice adipose tissue. The graph 
(figure 15)  shows a 3- and 2-fold increase of [U-14C]glucose uptake of 
Prep1i/+ adipocytes at basal and insulin-stimulated level, respectively. 





Figure 15: [U-14C]glucose uptake of adipocytes isolated from adipose tissue of WT and 
Prep1i/+ mice. 
Mature adipocytes were isolated as described in Material and Methods. Then were counted 
and aliquots were incubated in KRBH-5% BSA  with or without 100nM insulin for 30 minutes 
before adding  [U-14C]glucose (0.5μCi/ml) at 37° C on shaking. After 30 minutes aliquots of 
each samples were put in scintillation liquid for measurement of [U-14C]glucose on β-counter. 
Bar represents the mean ±SD of four independent experiments, in each of which reactions 
were performed in quintuple using adipocytes obtained from two mice for genotype 
(*P<0.05). 
 
To explain the increase of [U-14C]glucose uptake in Prep1 hypomorphic 
heterozygous adipocytes, I performed immunochemistry for GLUT4 in 
adipose tissue of Prep1i/+ and WT mice. Staining with specific antibody 
revealed significantly higher expression of GLUT4 on the plasma membrane 
of adipocytes of Prep1i/+ mice compared with that of control animals (figure 
16). This data was also consistent with the increased GLUT4 expression as 
showed in figure 12-13. 
 





Figure 16: Immunohistochemical analysis of adipose tissue from Prep1i/+ and WT mice. 
Sections from adipose tissue from 6-months-old Prep1i/+ and WT littermates were stained 
with hematoxylin-eosin and immunostained with GLUT4 antibody (original magnification 
40X). The microphotographs shown are representative of findings observation in six Prep1i/+ 
and five control animals. 
All together these data suggest that Prep1 could regulate adipocyte 
differentiation and adipose tissue functions. 
 
 
4.4 Prep1 protein expression is decreased during 3T3L1 adipocyte 
differentiation 
To better understand the Prep1 involvement in the regulation of 
adipogenesis, I evaluated in 3T3L1 cells, an established cell line of murine 
origin, whether the expression levels of Prep1 may change during adipocyte 
differentiation. To this aim, I induced differentiation in this cell line after 
reaching the state of confluence and I evaluated the protein expression of 
Prep1 during the different days of the differentiation process. As shown in 
figure 17, Prep1 protein levels were progressively reduced during the 
conversion from 3T3L1 preadipocytes to adipocytes (from day 0 to day 8), 
indicating that Prep1 down-regulation could be important for the 
differentiation process. 
. 




                                      
 
Figure 17: Prep1 protein expression during 3T3L1 adipocytes differentiation. 
3T3L1 cells were solubilized, lysed and analyzed by immunoblotting with Prep1 antibodies 
and autoradiography. Actin antibodies were used for normalization. Blot were revealed by 
ECL and autoradiograph subjected to densitometric analysis. The autoradiograph shown on 
the top of the graphic is representative of four independent experiments. Asterisks denote 
statistically differences (**P < 0.01). 
 
 
4.5 Prep1 stable transfection and Oil Red-O staining in 3T3L1 cells 
The data obtained in the Prep1i/+ mice were further investigated in 
stably transfecting Prep1 cDNA (PRC/CMV Prep1) or empty vector 
(PRC/CMV) in 3T3L1 cells. Cells were incubated with DMEM 10% FCS 
containing the antibiotic G418 (0.8 mg/mL) and several clones were obtained. 
Three of those, expressing increasing levels of Prep1, were selected and 
further characterized (figure 18A-B) and the 3T3L1Prep1c clone overexpressing 
Prep1 by 4-fold was used for the subsequent experiments. 
 







Figure 18: Prep1 stable transfection in 3T3L1 cells. 
A: 3T3L1 cells were stable transfected with Prep1 cDNA. Cells were then solubilized and 
lysates were analyzed by immunoblotting with Prep1 antibodies and autoradiography to verify 
the transfection. Actin antibodies were used for normalization. The autoradiograph shown is 
representative of three different experiments. B: The levels of Prep1  mRNA was quantitated 
by real-time RT-PCR analysis, using β-actin as internal standard. Bars represent the mean ± 
SD of four independent experiments. Asterisks denote statistically significant differences (*P 
< 0.05). 
 
Thus, I evaluated the effect of Prep1 overexpression on lipid accumulation as 
marker of adipocytes differentiation. Control (CTRL) and overexpressing 
Prep1 3T3L1 adipocytes were analyzed by microscopy after staining with Oil 
Red-O (ORO). In control 3T3L1 adipocytes, lipid droplets were clearly 
observed with light red cytoplasmic staining, as also shows by the ORO 
amount (figure 19A), while in 3T3L1 adipocytes overexpressing Prep1 
accumulation lipid droplets was barely detected (figure 19B). 
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Figure 19: Effect of Prep1 overexpression on lipid accumulation in 3T3L1 adipocytes. 
A: Control and stably overexpressing Prep1 3T3L1 adipocytes were stained with Oil Red-O as 
described in Materials and Methods. The photographs shown are representative of five 
independent experiments. B: After microscopic study, the ORO was extracted in 100% 
isopropanol and absorbance was evaluated at 510nm.  
 
 
4.6 Adipogenic markers expression and insulin signaling in 3T3L1 
adipocytes stably overexpressing Prep1 
To further examine the role of Prep1 on adipogenesis, I evaluated the 
mRNA and the protein expression of adipogenesis markers genes C/EBPα, 
PPARγ, GLUT4 and FABP4 in control and overexpressing Prep1 adipocytes. 
As shown in figure 20, the overexpression of Prep1 in 3T3L1 adipocytes 
induced a significant reduction of mRNA (figure 20A) and protein (figure 
20B) expression of C/EBPα, GLUT4 and FABP4 compared to the control 
3T3L1 adipocytes. PPARγ levels did not change between control and 
overexpressing Prep1 adipocytes. 
 





       
 
Figure 20: Adipogenic markers in Prep1 stably overexpressing 3T3L1 adipocytes. 
A: Control and stably overexpressing Prep1 3T3L1 cells were differentiated as described in 
Material and Methods.  The levels of C/EBPα, FABP4, GLUT4 and PPARγ  mRNA were 
quantitated by real-time RT-PCR analysis, using β-actin as internal standard. Bars represent 
the mean ±SD of four independent experiments. Asterisks denote statistically significant 
differences (*P< 0.05; ***P< 0.001). B: Cells were solubilized and lysates were analyzed by 
immunoblotting with C/EBPα, FABP4, GLUT4 and PPARγ  antibodies and autoradiography. 
Actin antibodies were used for normalization. The autoradiograph shown is representative of 
three different experiments.  
 
Next, I analyzed the insulin pathway in 3T3L1 adipocytes. As showed by 
Western blot experiments (figure 21), in control 3T3L1 adipocytes, 
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stimulation with insulin 100nM for 10 minutes induced the phosphorylation of 
IR-Tyr1146, AKT-Ser473, MAPK, while in adipocytes overexpressing Prep1 
insulin failed to elicit this effect. 
 
 
       
 
Figure 21: Insulin signaling in 3T3L1 adipocytes overexpressing Prep1 
Cells were solubilized and lysates were analyzed by immunoblotting with Prep1, pIR-
Tyr1146, IR, pAKT-Ser473, AKT, pMAPK, MAPK antibodies and autoradiography. Actin 
antibodies were used for normalization. The autoradiograph shown is representative of four 
different experiments. 
 
These data confirm the role of Prep1 in regulating both the adipose tissue 
differentiation and insulin action. 
 




In a modern lifestyle, people are chronically exposed to elevated 
amounts of lipids and nutrients potentially leading to tissue dysfunction and 
disease. The adipose tissue is highly involved in the development of metabolic 
disorders such as cardiovascular disease (CVD), obesity and type 2 diabetes 
mellitus (T2DM). It is the body’s largest storage site for triglycerides, and 
normally, fat storage takes place during food intake to be replaced by fat 
mobilization processes during fasting or situations with elevated energy 
demand. Adipocytes produce a number of endocrine hormones that contribute 
to the regulation of this mechanisms and of whole body homeostasis (Bjørndal 
et al. 2011). Knowledge of adipocyte biology is crucial for understanding the 
pathophysiological basis of obesity and type 2 diabetes. 
Previous studies have identified Prep1 as a physiologic regulator of glucose 
and lipid metabolisms (Oriente et al. 2008; Oriente et al. 2011; Oriente et al. 
2013). In Prep1-deficient mice, muscle sensitivity to insulin action on glucose 
disposal is significantly increased, due to down-regulation of an important 
Prep1 partner p160MBP and induction of the GLUT4 gene activator PGC-1α. In 
the liver, Prep1 silencing enhances insulin signaling, thereby increasing 
glucose storage and reducing glucose output. Indeed, Prep1 hypomorphic 
mice show increased hepatic glycogen content and decreased triglyceride 
levels. The potential significance of these findings to insulin-resistance and 
diabetes mellitus is further underlined by our experiments in the L6 skeletal 
muscle and HepG2 human hepatoma cell lines evidencing that overexpression 
of Prep1 induces resistance to insulin action. In addition, Prep1 deficiency 
decreases triglyceride synthesis in liver and this effect is due to an increase of 
PKCζ, LKB1, AMPK and ACC phosphorylation, which determines the 
reduction of FAS expression. These effects are paralleled by a significant 
decrease of the lipid phosphatase SHIP2, that negatively regulates this 
pathway. Consistent with these data, Prep1 gene silencing protects mice from 
the TG accumulation and hepatocyte damage caused by a methionine-choline 
deficient diet administration. 
It is well established that Prep1 regulates several aspects of whole body 
homeostasis, even though its impact on adipose compartment is still unknown. 
In the present work, I show that Prep1 deficiency induces a reduction of 
adipose mass in mice, with a decrease of adipocyte cell area without variations 
of cell number. Adipocytes are dynamic cells and their expansion is critical for 
insulin sensitivity and overall metabolic health. Furthermore, adipose tissue 
functionality is closely related to the adipocytes differentiation state, I focused 
my attention on adipogenesis. The development of fully differentiated mature 
adipocytes from precursor cells is an elegant progression involving the 
sequential activation of several transcription factors (Stephens 2012). The 
activation of these transcription factors leads to expression of protein 
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necessary to established adipocyte phenotype. Early events of the adipogenic 
process include the activation of C/EBPα and PPARγ, critical pro-adipogenic 
transcription factors, that determine the expression of proteins involved in 
glucose and lipid metabolism, such as GLUT4 and FABP4; all these genes are 
usually considered adipogenic markers of differentiation. My results show that 
the mRNA and protein expression of C/EBPα, GLUT4 and FABP4 are 
increased in adipose tissue of Prep1i/+ mice. Interestingly, expression levels of 
PPARγ are unchanged in Prep1 hypomorphic heterozygous mice. It has been 
demonstrated that mice in which PPARγ was ablated in adipocytes became 
lipodystrophic (He et al. 2003), but on the other hand, PPARγ-/+ mice were 
protected from adipocytes hypertrophy and insulin resistance under high-fat 
diet treatment (Kubota et al. 1999). It is clear that PPARγ plays an important 
role in adipose tissue homeostasis and it is plausible that in adipose tissue of 
Prep1i/+ mice several compensatory mechanisms act to preserve PPARγ  
expression and so fat compartment. 
Critical to adipocyte functions is the capacity to respond to insulin, and this 
feature is acquired during adipogenesis when mature cells arise from 
preadipocytes. In addition, it has well been demonstrated that Prep1 
hypomorphic heterozygous mice show better insulin sensitivity. So, upon  
intraperitoneal insulin injection, my results demonstrate that Prep1i/+ mice 
show a significant increase of IR tyrosine phosphorylation, in parallel with an 
increase activation of the downstream effectors AKT and MAPK. This higher 
capacity to respond to insulin stimulation is accompanied by an increase of 
basal and insulin-stimulated [U-14C]glucose uptake of mature adipocytes 
isolated from Prep1i/+ mice adipose tissue. The increase of [U-14C]glucose 
uptake in these mice is most likely due to higher persistence of GLUT4 on the 
plasma membrane of adipocytes. These data demonstrate that Prep1may play 
a role also in adipose tissue functions. 
To address the hypothesis that Prep1 can regulate adipose tissue functions 
through its capacity to affects adipocytes differentiation, I evaluated Prep1 
protein expression during adipogenesis in a cellular model, murine 3T3L1. 
3T3L1 preadipocytes are fibroblastic cells determined to the adipocyte lineage 
and fully differentiated 3T3L1 adipocytes possess most of the morphological, 
biochemical and hormonal response characteristics of adipocytes in vivo 
(Sadowski et al. 1992). My results show that Prep1 protein abundance 
decreases during the conversion of 3T3L1 preadipocytes to adipocytes, in 
particular at the last days of adipogenic process. This data indicates that the 
absence of Prep1 could be important for adipocytes differentiation. To further 
investigate my hypothesis, I stably transfected 3T3L1 preadipocytes with full-
length Prep1 cDNA. The 3T3L1 adipocytes overexpressing Prep1, after Oil 
Red-O staining, show a reduction of lipid accumulation. In addition, at the 
opposite to the adipose tissue of Prep1i/+ mice, the overexpression of Prep1 
significantly reduces the mRNA and protein expression of the adipogenic 
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markers C/EBPα, GLUT4 and FABP4, while PPARγ levels does not change. 
These data indicate that Prep1 affects adipocyte differentiation. In addition, 
Prep1 overexpression in 3T3L1 adipocytes induces a reduction of insulin 
receptor, AKT and MAPK phosphorylation, indicating that Prep1 impact on 
adipogenesis is also paralleled by an impairment of  3T3L1 adipocytes 
functions. Further experiments will be needed to clarify the molecular 
mechanisms by which Prep1 regulates expression of adipogenic genes and 
insulin pathway. 
In summary, the major finding of the present study is that Prep1 induces 
adipose tissue dysfunction probably through an impairment of adipocyte 
differentiation. Although the precise molecular mechanisms and signaling 
pathways regulated by Prep1 remain to be better clarified, suppression of this 
transcription factor may represent a beneficial strategy in the treatment of 
obesity and thereby prevent type 2 diabetes. Nevertheless, as my data have 
been obtained in murine models, another important point which I would like to 
study in the future is the clinical relevance of Prep1 in humans. We have 
preliminary data showing that first-degree relatives of type 2 diabetics (these 
individuals have an high risk of type 2 diabetes) feature 3.5-fold higher Prep1 
levels compared to control individuals with no family history of diabetes. In 
addition, in these first-degree relatives, Prep1 expression levels negatively 
correlate with insulin sensitivity. These subjects have a very high risk of 
diabetes and are known to be insulin-resistant, suggesting that Prep1 
overexpression may provide an early contribution to diabetes progression in 
these individuals. However, whether Prep1 overexpression induces insulin-
resistance in human and whether it is sufficient to impair glucose tolerance is 













Human obesity is characterized by an excess of adipose tissue mass 
that has potential adverse health consequences and may finally result in a 
reduced quality of life and life expectancy. Among the many complications 
that are associated with obesity, disturbances of glucose metabolism and 
cardiovascular system are of particular relevance. Excess body fat promotes 
the development of type 2 diabetes mellitus and dyslipidemia, favors other 
cardiovascular risk factors such as hypertension and impaired fibrinolysis and 
may therefore result in an increased incidence of cardiovascular 
complications. The precise causal relationship between obesity and these 
disturbances is only poorly understood, but there is growing evidence that 
alterations in fat cell function may directly or indirectly contribute to the 
development of these unfavorable health hazards (Hauner & Skurk 2001). 
In the present work I have focused my attention on Prep1 effects on adipose 
compartment. I have described that Prep1i/+ mice show a reduction of 
epididymal adipose tissue weight, a reduction of the adipocyte area but not 
changes in the number of adipocytes. In addition, expression of adipogenic 
markers, C/EBPα, GLUT4 and FABP4, is increased in adipose tissue of 
Prep1i/+ mice, while PPARγ does not change. These effects are paralleled by 
increased phosphorylation of insulin receptor (IR), AKT and MAPK in 
adipose tissue of Prep1i/+ mice. In addition, basal and insulin- stimulated 
glucose-uptake is increased in adipocytes isolated from adipose tissue of 
Prep1i/+ mice compared to the adipocytes from WT mice. This increase is 
accompanied by the higher expression of GLUT4 on the plasma membrane of 
adipocytes of Prep1i/+ mice. 
In conclusion, these findings have contributed to underline the link between 
Prep1 and adipose tissue compartment and to clarify its role in the regulation 
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